About
Saliva-based diagnostic testing
Areas of Focus
Categories
DiagnosticsSeattle/Pacific Northwest
Clinical Trials (14)
View allTotal Trials
14
As Lead Sponsor
5
As Collaborator
9
Total Enrollment
12,307
By Phase
NA: 2PHASE2: 2PHASE3: 1
By Status
COMPLETED: 9TERMINATED: 2WITHDRAWN: 1UNKNOWN: 1ACTIVE_NOT_RECRUITING: 1
Clinical Trials Pipeline14 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
1989
1990
1991
1992
1993
1994
1995
1996
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT02111031Lead Sponsor
Clinical Utility of CTC Test in Medicare-Eligible Metastatic Breast Cancer Patients
N/AWithdrawn
Started: Jan 31, 2016 · Completed: May 31, 2017
NCT02064972Collaborator
CEC Count Changes to Support GvHD Diagnosis.
N/ACompleted
50 participants
Started: Apr 30, 2014 · Completed: Mar 31, 2016
NCT02080650Collaborator
Characterization of Circulating Tumor Cells Captured by c-MET (CTC-MET)
NACompleted
62 participants
Started: Mar 31, 2014 · Completed: Jul 19, 2016
NCT01548677Collaborator
Efficacy Study of Herceptin to Treat HER2-negative CTC Breast Cancer
PHASE2Completed
1,317 participants
Started: Apr 30, 2013 · Completed: Mar 31, 2017
NCT01701050Lead Sponsor
Characterization of Circulating Tumor Cells (CTC) From Patients With Metastatic Breast Cancer Using the CTC-Endocrine Therapy Index
N/ACompleted
121 participants
Started: Apr 1, 2013 · Completed: Nov 10, 2016
Locations (1)
Headquarters
Vancouver, WA, United States
Map
Loading map...